3-{2,4-dimethylpyrimido[1,2-b]indazol-3-yl}-N-[2-(2-methyl-1H-1,3-benzodiazol-1-yl)ethyl]propanamide

Dear Customer,

We are working. Read MolPort blog with latest update on Covid-19 effect on compound sourcing, our suppliers, logistics, services & answers on FAQ.

MolPort Team


Compound number:
MolPort-009-150-094
IUPAC:
3-{2,4-dimethylpyrimido[1,2-b]indazol-3-yl}-N-[2-(2-methyl-1H-1,3-benzodiazol-1-yl)ethyl]propanamide
IUPAC traditional:
3-{2,4-dimethylpyrimido[1,2-b]indazol-3-yl}-N-[2-(2-methyl-1,3-benzodiazol-1-yl)ethyl]propanamide
SMILES:
Cc1nc2ccccc2n1CCNC(=O)CCc1c(C)nc2c3ccccc3nn2c1C
InChI key:
WBGDHGZKIUWRQY-UHFFFAOYSA-N
Molecular formula:
C25H26N6O
Molecular weight: 426.524
Solubility: not available

Marketplace Offers

S&H to USA: 50.00 USD
S&H to World: 120.00 USD

Supplier Catalogue Data


Catalog: Screening compound Ships out: 10 business days Purity: >90%
Last updated: > 3 months ago In warehouse: 212.00 mg
Pack size Ships out Price Qty
1 mg June 11, 2020 61.00 USD
ADD TO CART
2 mg June 11, 2020 62.00 USD
ADD TO CART
5 mg June 11, 2020 65.00 USD
ADD TO CART

More Information

Compound Identifiers
Compound number: MolPort-009-150-094

Names, Synonyms and 3rd Party Identifiers

InChI
InChI: 1S/C25H26N6O/c1-16-19(17(2)31-25(27-16)20-8-4-5-9-21(20)29-31)12-13-24(32)26-14-15-30-18(3)28-22-10-6-7-11-23(22)30/h4-11H,12-15H2,1-3H3,(H,26,32)
InChI key: WBGDHGZKIUWRQY-UHFFFAOYSA-N

Calculated Properties
Molecular formula: C25H26N6O
Molecular weight: 426.524

Other

Sales contact

+1 215 717 7447

+371 67790398

sales@molport.com


Our customer services department will be happy to help you Monday to Friday 7 a.m. to 9 p.m. GMT (2 a.m. - 4 p.m. EST).


2020 MolPort, v3.71, release date 27-05-2020 12:00 (+0200). All rights reserved.
This website or its third-party tools use cookies, which are necessary to its functioning and require to achieve the purposes illustrated in the Cookie Policy. If you want to know more or withdraw your consent to all or some of the cookies, please refer to the Cookie Policy. By clicking on Agree and closing this banner, scrolling this page, clicking a link or continuing to browse otherwise, you agree to the use of cookies.